This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Brown, R.D. and Martin. Y.C., Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection, J. Chem. Inf. Comp. Sci., 36 (1996), 572–584.
Pearlman, R.S., Novel software tools for addressing chemical diversity, NetSci, http://www.awod.com/netsci, 2 (1996), 1.
Pearlman. R.S., Diverse Solutions User’s Manual, Universityof Texas, Austin. TX, 1996.
Burden. F.R., Molecularidentification number for substructure searches, J.Chem.Inf.Comp.Sci., 29 (1989), 225–7.
Rusinko III, A. and Lipkus. A.H., unpublished results obtained at ChemicalAbstracts Service,Columbus OH.
Pearlman, R.S. and Smith, K.M., manuscript in preparation.
Weintraub, H.J.R. and Demeter, D.A., personal communication.
Pearlman, R.S. and Deanda, F., manuscript in preparation.
Sweet, C.S., Ulm, E.H., Gross, D.M., Vassil, T.C. and Stone, C.A., Anew class ofangiotensin-converting enzyme inhibitors, Nature, 288 (1980) 280–283.
Suh, J.T., Skiles, J.W., Williams, B.E., Youssefyeh, R.D., Jones, H., Loev, B., Neiss, E.S., Schwab, A., Mann, W.S., Khandwala, A., Wolf, P.S., and Weinryb, I., Angiotensin-ConvertingEnzyme Inhibitors New Orally active antihypertensive (Mercaptoalkanoyl)-and [(Acylthio)alkanoyl]glycine derivatives, J. Med. Chem., 28 (1985) 57–66.
Menard, P.R., Suh, J.T., Jones, H., Loev, B., Neiss, E.S., Wilde, J., Schwab, A., and Mann, W.S., Angiotensin-ConvertingEnzyme Inhibitors. (Mercaptoaroyl)amino acids, J. Med. Chem., 28 (1985) 328–332.
Wyvratt, M.J. and Patchett, A.A., Recent developments in the design of angiotensin-converting enzyme inhibitors, Med. Res. Rev., 5 (1985) 483–531.
Karanewsky, D.S., Badia, M.C., Cushman, D.W., DeForrest, J.M., Dejneka, T., Loots, M.J., Perri, M.G., Petrillo, E.W., and Powell, J.R., (Phosphinyloxy)acyl amino acid inhibitorsofangiotensin-converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-l-oxohexyl-L-proline novel orally active inhibitor of ACE, J. Med. Chem., 31 (1988) 204–212.
Yanagisawa, H., Ishihara, S., Ando, A., Kanazaki, T., Miyamoto, S., Koike, H., Iijima, Y., Oizumi, K., Matsushita, Y. and Hata, T., Angiotensin-Converting Enzyme Inhibitors. 2. Perhydroazepin-2-one deriv-atives. J. Med. Chem., 31 (1988) 422–428.
Krapcho, J., Turk, C., Cushman, D.W., Powell, J.R., DeForrest, J.M., Spitzmiller, E.R., Karanewsky, D.S., Duggan, M., Rovnyak, G., Schwwartz, J., Natarajan, S., Godfrey, J.D., Ryono, D.E., Neubeck, R., Atwal, K.S., and Petrillo, E.W., Angiotensin-Converting Enzyme Inhibitors.Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substitutedprolines, J. Med. Chem., 31 (1988) 1148–1160.
Karanewsky, D.S., Badia, M.C., Cushman, D.W., DeForrest, J.M., Dejneka, T., Lee, V.G., Loots, M.J., and Petrillo, E.W., (Phosphinyloxy)acyl amino acid inhibitors of angiotensin-converting enzyme. 2. Terminal amino acid analogues of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline, J. Med. Chem., 33 (1990) 1459–1469.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Pearlman, R.S., Smith, K.M. (2002). Novel Software Tools for Chemical Diversity. In: Kubinyi, H., Folkers, G., Martin, Y.C. (eds) 3D QSAR in Drug Design. Three-Dimensional Quantitative Structure Activity Relationships, vol 2. Springer, Dordrecht. https://doi.org/10.1007/0-306-46857-3_18
Download citation
DOI: https://doi.org/10.1007/0-306-46857-3_18
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-4790-3
Online ISBN: 978-0-306-46857-5
eBook Packages: Springer Book Archive